Cost Effectiveness of the New Pneumococcal Vaccines: A Systematic Review of European Studies
The European studies we analysed are mostly based on weak sources of data. Because of the limited information on vaccine effectiveness and lack of epidemiological and economic data, the need for extensive recourse to assumptions leads to great within- and between-study variability generated by authors’ choices. </AbstractSection> Copyright Springer International Publishing Switzerland 2014
Year of publication: |
2014
|
---|---|
Authors: | Vooren, Katelijne ; Duranti, Silvy ; Curto, Alessandro ; Garattini, Livio |
Published in: |
PharmacoEconomics. - Springer, ISSN 1170-7690. - Vol. 32.2014, 1, p. 29-45
|
Publisher: |
Springer |
Saved in:
Online Resource
Saved in favorites
Similar items by person
-
A Critical Systematic Review of Budget Impact Analyses on Drugs in the EU Countries
Vooren, Katelijne, (2014)
-
Biosimilar Versus Generic Drugs: Same But Different?
Vooren, Katelijne, (2015)
-
Italian risk-sharing agreements on drugs: are they worthwhile?
Garattini, Livio, (2015)
- More ...